The Supriya Lifescience IPO open date is Dec 16, 2021. Supriya Lifescience manufactures Active pharmaceutical ingredients (APIs). It produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic as of March 2021.
The Supriya Lifescience has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between the Fiscal year 2017 and 2021. It is also one of the largest exporters of Salbutamol Sulphate from India in FY 2021
In the year 2021, the company’s products were exported to 86 countries to 1,296 customers including 346 distributors. The company has API business in Europe, Latin America, Asia, and North America.
The company’s manufacturing facility has received approvals from USFDA, EDQM TGA-Australia, KFDA-Korea, PMDA Japan, NMPA (previously known as SFDA)- China, Health Canada, in relation to API products being exported to the relevant jurisdictions by the company.
Also check: Upcoming IPOs List 2021
Table of Contents
Supriya Lifescience IPO – Financial Information
Here is the list of Supriya Lifescience limited financial information.
| 30-Sep-21 | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |
| Total Assets | 5,041.02 | 4,458.24 | 3,364.01 | 2,530.52 |
| Total Revenue | 2,300.61 | 3,962.21 | 3,227.13 | 2,858.62 |
| Profit After Tax | 659.59 | 1,238.28 | 733.74 | 394.24 |
Supriya Lifescience IPO – Objects of the Issue
The net proceeds from the IPO will be utilized for the following purposes
- Funding capital expenditure requirements of the company
- Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the company
- General corporate purposes
Supriya Lifescience IPO – IPO Details
Here is the list of the IPO Details of Supriya Lifescience Limited.
| IPO Opening Date | Dec 16, 2021 |
| IPO Closing Date | Dec 20, 2021 |
| Issue Type | Book Built Issue IPO |
| Face Value | Rs 2 per equity share |
| IPO Price | Rs 265 to Rs 274 per equity share |
| Market Lot | 54 Shares |
| Min Order Quantity | 54 Shares |
| Listing At | BSE, NSE |
| Issue Size | Eq Shares of Rs 2(aggregating up to Rs 700.00 Cr) |
| Fresh Issue | Eq Shares of Rs 2(aggregating up to Rs 200.00 Cr) |
| Offer for Sale | Eq Shares of Rs 2(aggregating up to Rs 500.00 Cr) |
| QIB Shares Offered | Not less than 75% of the Offer |
| Retail Shares Offered | Not more than 10% of the Offer |
| NII (HNI) Shares Offered | Not more than 15% of the Offer |
Supriya Lifescience IPO – Tentative Timetable
The Supriya Lifescience IPO open date is Dec 16, 2021, and the close date is Dec 20, 2021. The issue may list on Dec 28, 2021.
| IPO Open Date | Dec 16, 2021 |
| IPO Close Date | Dec 20, 2021 |
| Basis of Allotment Date | Dec 23, 2021 |
| Initiation of Refunds | Dec 24, 2021 |
| Credit of Shares to Demat Account | Dec 27, 2021 |
| IPO Listing Date | Dec 28, 2021 |
Supriya Lifescience IPO – Lot Size
The Supriya Lifescience IPO market lot size is 35 shares. A retail-individual investor can apply for up to 13 lots which is 455 shares or Rs 193,375.
| Application | Lots | Shares | Amount (Cut-off) |
| Minimum | 1 | 54 | Rs 14,796 |
| Maximum | 13 | 702 | Rs 192,348 |
Company Contact Information
Supriya Lifescience Limited
207/208, Udyog Bhavan,
Sonawala Road, Goregaon,
East, Mumbai – 400063, Maharashtra, India
Phone: +91-22-40332727
Email: cs@supriyalifescience.com
Website: https://supriyalifescience.com/
Supriya Lifescience IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: supriyalife.ipo@linkintime.co.in
Website: https://linkintime.co.in/
